NovaBay Pharmaceuticals (NBY) Receivables - Net (2016 - 2025)
Historic Receivables - Net for NovaBay Pharmaceuticals (NBY) over the last 15 years, with Q3 2025 value amounting to $368000.0.
- NovaBay Pharmaceuticals' Receivables - Net fell 4772.73% to $368000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $368000.0, marking a year-over-year decrease of 4772.73%. This contributed to the annual value of $680000.0 for FY2023, which is 6553.47% down from last year.
- As of Q3 2025, NovaBay Pharmaceuticals' Receivables - Net stood at $368000.0, which was down 4772.73% from $704000.0 recorded in Q3 2024.
- NovaBay Pharmaceuticals' 5-year Receivables - Net high stood at $2.6 million for Q2 2023, and its period low was $200000.0 during Q1 2022.
- Its 5-year average for Receivables - Net is $1.2 million, with a median of $977000.0 in 2021.
- Per our database at Business Quant, NovaBay Pharmaceuticals' Receivables - Net tumbled by 8073.22% in 2022 and then surged by 81750.0% in 2023.
- Quarter analysis of 5 years shows NovaBay Pharmaceuticals' Receivables - Net stood at $1.7 million in 2021, then increased by 18.29% to $2.0 million in 2022, then plummeted by 65.53% to $680000.0 in 2023, then rose by 3.53% to $704000.0 in 2024, then tumbled by 47.73% to $368000.0 in 2025.
- Its Receivables - Net was $368000.0 in Q3 2025, compared to $704000.0 in Q3 2024 and $547000.0 in Q2 2024.